John Markley Defends Thesis
DOCTORAL DISSERTATION LECTURE
Tumor-Specific Human Primary T cells Engineered to Overexpress IL-2, IL-7, IL-15, or IL-21 Confer Varying Degrees of Tumor Rejection and Xenogeneic Graft-Versus-Host Disease in an Immunodeficient Mouse Model.
By
John Charles Markley
Candidate for the Degree of Doctor of Philosophy
Tuesday, November 18, 2008, at 12:00 p.m.
Room: S-1132
Sloan-Kettering Schwartz Building
1250 First Avenue
Students, Faculty, and Guests of the Tri-Institutional Academic Community are invited to attend.
FINAL EXAMINATION
The public lecture will be followed by a defense of the thesis, at which attendance will be
restricted to the Examining Committee and other interested members of the Faculty of the
Weill Cornell Graduate School of Medical Sciences.
Examining Committee
Dr. Richard O'Reilly, Chairperson
Dr. Alan Houghton*
Dr. Xiaojing Ma*
Dr. Michel Sadelain*+
Dr. Marcel van den Brink*
*Special Committee +Major Sponsor
Powered by Big Medium™
